Heidrun Moll

Josef Schneider Str. 2
Wuerzburg, BY 97080, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Inhibitory effect of phenothiazine- and phenoxazine-derived chloroacetamides on Leishmania major growth and Trypanosoma brucei trypanothione reductase.

Inhibitory effect of phenothiazine- and phenoxazine-derived chloroacetamides on Leishmania major growth and Trypanosoma brucei trypanothione reductase.

Journal: European journal of medicinal chemistry

Published: May 27, 2015

Pathogen- and Host-Directed Antileishmanial Effects Mediated by Polyhexanide (PHMB).

Pathogen- and Host-Directed Antileishmanial Effects Mediated by Polyhexanide (PHMB).

Journal: PLoS neglected tropical diseases

Published: April 14, 2015

Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases.

Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases.

Journal: Antimicrobial agents and chemotherapy

Published: March 03, 2015

Antileishmanial and cytotoxic compounds from Valeriana wallichii and identification of a novel nepetolactone derivative.

Antileishmanial and cytotoxic compounds from Valeriana wallichii and identification of a novel nepetolactone derivative.

Journal: Molecules (Basel, Switzerland)

Published: February 24, 2015

Identification of multiple cellular uptake pathways of polystyrene nanoparticles and factors affecting the uptake: relevance for drug delivery systems.

Identification of multiple cellular uptake pathways of polystyrene nanoparticles and factors affecting the uptake: relevance for drug delivery systems.

Journal: European journal of cell biology

Published: May 15, 2014

Cathepsin B in antigen-presenting cells controls mediators of the Th1 immune response during Leishmania major infection.

Cathepsin B in antigen-presenting cells controls mediators of the Th1 immune response during Leishmania major infection.

Journal: PLoS neglected tropical diseases

Published: April 04, 2014

Antileishmanial lead structures from nature: analysis of structure-activity relationships of a compound library derived from caffeic Acid bornyl ester.

Antileishmanial lead structures from nature: analysis of structure-activity relationships of a compound library derived from caffeic Acid bornyl ester.

Journal: Molecules (Basel, Switzerland)

Published: December 23, 2013

A novel Leishmania major amastigote assay in 96-well format for rapid drug screening and its use for discovery and evaluation of a new class of leishmanicidal quinolinium salts.

A novel Leishmania major amastigote assay in 96-well format for rapid drug screening and its use for discovery and evaluation of a new class of leishmanicidal quinolinium salts.

Journal: Antimicrobial agents and chemotherapy

Published: April 17, 2013

T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.

T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.

Journal: PLoS pathogens

Published: August 10, 2012

Dendritic cell-mediated vaccination relies on interleukin-4 receptor signaling to avoid tissue damage after Leishmania major infection of BALB/c mice.

Dendritic cell-mediated vaccination relies on interleukin-4 receptor signaling to avoid tissue damage after Leishmania major infection of BALB/c mice.

Journal: PLoS neglected tropical diseases

Published: January 11, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026